Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies

Journal of Inflammation

Poster Presentation

Jigyasa Arora¹  Ralf Michael Zwacka¹  Andrea Mohr¹ 

[1] School of Biological Sciences, University of Essex, Wivenhoe Park, CO4 3SQ, Colchester, Essex, UK;

关键词: Programme Cell Death;    Drug Response;    Cytosolic Fraction;    Release Assay;    Single Cell Level;   

DOI  :  10.1186/1476-9255-12-S1-P5

来源: Springer

【 授权许可】

Unknown   
© Arora et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.